Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate

Author: Benzinga Newsdesk | May 07, 2024 07:06am
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. The company reported quarterly sales of $792.497 million which beat the analyst consensus estimate of $769.867 million by 2.94 percent. This is a 6.43 percent increase over sales of $744.626 million the same period last year.

Posted In: AHCO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist